Zhang Jing, Zhu Qin-Bing, Zeng Yu-Sha, Xue Ya-Hong
Graduate School, Nanjing University of Chinese Medicine, Nanjing, China.
Anorectal, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
Front Med (Lausanne). 2025 May 13;12:1538114. doi: 10.3389/fmed.2025.1538114. eCollection 2025.
As a series of bothersome bowel dysfunction symptoms, low anterior resection syndrome (LARS) has a high incidence after rectal cancer surgery, which grievously impairs health-related quality of life. There have been an increasing number of studies on biofeedback therapy (BFT) to recover intestinal function in patients following anus-preserving surgery. However, few systematic reviews or meta-analyses have been reported.
The purpose of this systematic review with meta-analysis was to identify the short-term and long-term effects of BFT on subjective and objective indicators of LARS.
Randomized controlled trials (RCT) published in PubMed, Cochrane Library, Web of Science, Embase, Chinese National Knowledge Infrastructure (CNKI), Wan Fang Data, China Biology Medicine disc (CBM), and Wei Pu (VIP) database from January 2012 to June 2024 were systematically searched. In accordance with PRISMA guidelines, the pooled findings were examined by Review Manager version 5.4.
The review finally included 14 RCT studies, with a total of 1,126 relevant patients. The meta-analysis results showed that following BFT, the mean resting pressure of the anal canal (MD = 5.53; 95% CI: 2.57, 8.49; Z = 3.66; = 0.0003), the mean initial rectal sensation threshold (MD = 3.04; 95% CI: 1.84, 4.24; Z = 4.96; < 0.00001), and the incidence rate of LARS (RR = 0.42; 95% CI: 0.31, 0.57; Z = 5.60; < 0.00001) in the BFT intervention group were significantly better than those in the control group, However, there was no statistically significant differences in the Memorial Sloan-Kettering Cancer Center (MSKCC) intestinal function questionnaire score (MD = 0.79; 95% CI: -0.35, 1.93; Z = 1.37; = 0.17), the CCIS (Wexner incontinence score) (MD = -0.67; 95% CI: -2.12, 0.78; Z = 0.91; = 0.36), the LARS score (MD = -2.35; 95% CI: -6.07, 1.37; Z = 1.24; = 0.22) and Xu ZF et al. "Five points Ten scores" excellent rate (RR = 4.59; 95% CI: 0.37, 56.35; Z = 1.19; = 0.23) between the two groups.
Our systematic review and meta-analysis indicate that BFT may improve the mean resting pressure of the anal canal and the mean initial rectal sensation threshold, reducing the incidence rate of LARS. Still, high-quality studies are necessary to explore the BFT standard for LARS.
PROSPERO: CRD42024519785, https://www.crd.york.ac.uk/PROSPERO/view/CRD42024519785.
作为一系列令人困扰的肠道功能障碍症状,低位前切除综合征(LARS)在直肠癌手术后发病率较高,严重损害患者的健康相关生活质量。目前,关于生物反馈疗法(BFT)促进保肛手术后患者肠道功能恢复的研究日益增多。然而,鲜有系统评价或Meta分析报道。
本系统评价及Meta分析旨在明确BFT对LARS主观和客观指标的短期及长期影响。
系统检索PubMed、Cochrane图书馆、Web of Science、Embase、中国知网(CNKI)、万方数据、中国生物医学文献数据库(CBM)和维普(VIP)数据库中2012年1月至2024年6月发表的随机对照试验(RCT)。按照PRISMA指南,采用Review Manager 5.4软件对汇总结果进行分析。
本评价最终纳入14项RCT研究,共1126例相关患者。Meta分析结果显示,BFT干预组肛管平均静息压(MD = 5.53;95%CI:2.57,8.49;Z = 3.66;P = 0.0003)、直肠初始感觉阈值均值(MD = 3.04;95%CI:1.84,4.24;Z = 4.96;P < 0.00001)及LARS发生率(RR = 0.42;95%CI:0.31,0.57;Z = 5.60;P < 0.00001)均显著优于对照组。然而,两组在纪念斯隆凯特琳癌症中心(MSKCC)肠道功能问卷评分(MD = 0.79;95%CI:-0.35,1.93;Z = 1.37;P = 0.17)、CCIS(Wexner失禁评分)(MD = -0.67;95%CI:-2.12,0.78;Z = 0.91;P = 0.36)、LARS评分(MD = -2.35;95%CI:-6.07,1.37;Z = 1.24;P = 0.22)及徐泽锋等的“五点十分制”优良率(RR = 4.59;95%CI:0.37,56.35;Z = 1.19;P = 0.23)方面差异均无统计学意义。
本系统评价及Meta分析表明,BFT可能提高肛管平均静息压和直肠初始感觉阈值均值,降低LARS发生率。但仍需高质量研究探索LARS的BFT标准。
PROSPERO:CRD42024519785,https://www.crd.york.ac.uk/PROSPERO/view/CRD42024519785